Genetic screening identifies glial adenosine as a therapeutic target in alpha-synucleinopathy
Maggie Sodders, E Okorie, H Tahmasebidehkordi…·Abby L. Olsen
A Drosophila genetic screen identifies glial adenosine metabolism genes as therapeutic targets for alpha-synucleinopathies by improving locomotion and reducing neurodegeneration.